by Eric Hamilton, University of Wisconsin-Madison University of Wisconsin-Madison scientists have discovered that a majority of back-pain patients they tested who were taking opioid painkillers produced anti-opioid antibodies. These antibodies may contribute to some of the negative side effects of long-term opioid use. Existing antibodies may also limit the benefit a patient receives from an...
12 August 2020, 6:51 am EDT By CJ Robles Tech Times Bill Gates has been super vocal about how the United States has been handling the coronavirus pandemic. With more than 5 million confirmed cases in the U.S., the Microsoft co-founder has been making calls for the government and businessmen alike to ensure that everyone...
by University of Chicago Medical Center The ongoing COVID-19 pandemic is shining a bright spotlight on vaccine development. As numerous vaccines race through clinical trials, physicians and researchers continue to work on developing new vaccine technologies to generate the most effective vaccines with the fewest side effects. A new proof-of-concept study by researchers at the...
By Madeline Holcombe, CNN (CNN)Coronavirus symptoms can stick around for weeks, even in otherwise healthy people who don’t have a severe case of the virus, the US Centers for Disease Control and Prevention said in a grim new analysis. The CDC surveyed 292 people who tested positive for the virus, and 35% said they still...
A surprising new concept for boosting the power of flu vaccines might also boost future COVID-19 vaccines CINCINNATI CHILDREN’S HOSPITAL MEDICAL CENTER UNDESIRED EXCESSIVE INTERLEUKIN-10 (IL-10) PRODUCTION IN AGED MICE COMES PRIMARILY FROM TFH CELLS, ACCORDING TO NEW FINDINGS PUBLISHED IN SCIENCE ADVANCES. THIS CHART SHOWS THAT WHEN THESE CELLS ARE STIMULATED… view more CREDIT:...
by Marilynn Marchione In this Friday, June 12, 2020 file photo, a woman has blood drawn for COVID-19 antibody testing in Dearborn, Mich. Research published on Tuesday, July 21, 2020 suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness. (AP Photo/Paul...
By HARRIET ALEXANDER FOR DAILYMAIL.COM Cholesterol-lowering drug Fenofibrate (Tricor) is providing a glimmer of hope Scientists in New York and Jerusalem believe the drug could help treat COVID The drug could reduce symptoms so that COVID-19 is no worse than a common cold, the study found Two scientists researching a potential treatment for coronavirus believe...
by Johns Hopkins University Bloomberg School of Public Health Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health. The results have implications for flu...
by Harvard University Red blood cells do more than shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens on their surfaces, neutralizing them, and presenting them to immune cells in the spleen and liver. Now, a team of researchers from Harvard’s Wyss Institute for Biologically...
by Cardiff University New markers hidden inside the influenza virus have been discovered by scientists at Cardiff University. The researchers from the School of Medicine worked with an international team of experts—including collaborators in Moscow, Russia and Melbourne, Australia—to look at how people’s immune systems responded to the new proteinmarkers. They showed for the first...
